Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MMW +PAN | Ann: Buy-out of MMW Convertible Securities Follow | 29/06/12 | 0 | 814 | |||
|
|||||||
MMW | Ann: Removal from Official List cob 28/06/12 | 27/06/12 | 0 | 824 | |||
|
|||||||
MMW +PAN | Ann: Change of Magma Metals Board | 26/06/12 | 0 | 1.1K | |||
|
|||||||
MMW | adieu mmw | 16/06/12 | 0 | 918 | |||
|
|||||||
MMW | Ann: Suspension from Official Quotation at close | 14/06/12 | 0 | 804 | |||
|
|||||||
MMW +PAN | Ann: Notice of compulsory acquisition from PAN (F | 14/06/12 | 0 | 963 | |||
|
|||||||
MMW +PAN | News: Panoramic acquires more than 90% of Magma | 07/06/12 | 0 | 643 | |||
|
|||||||
MMW +PAN | Ann: PAN acquires more than 90% of MMW at end of | 07/06/12 | 0 | 815 | |||
|
See All Discussions